- Tous > Medicine Information and Evidence for Policy > Medicines Policy
- Tous > Medicine Access and Rational Use > Rational Use
- Mots-clés > medicines - supply chain
- Mots-clés > pharmaceutical human resources
- Mots-clés > pharmaceutical supply chain
- Mots-clés > pharmacist
- Mots-clés > pharmacist - role and responsibility
- Mots-clés > supply chain - stock-outs
- Mots-clés > supply chain management
- Mots-clés > use of medicines
- Mots-clés > farmacéutico
- Mots-clés > uso de medicamentos
(2018; 95 pages)
Inefficient pharmaceutical supply chains are partly to blame for a substantial proportion of the world still being without access to basic live-saving medicines, the International Pharmaceutical Federation (FIP) says in a new report, published today. The report, “Pharmacists in the supply chain: The role of the medicines expert in ensuring quality and availability”, is released in a landscape of challenges such as substandard and falsified medicines, and a shortage of human resources in the health supply chain. “The need to ensure effective and safe medicines supply prompted FIP to take a close look at the actual role of pharmacists in pharmaceutical supply chains.
The pharmaceutical supply chain encompasses the full life cycle of a medicine, from raw material through to use by patients. Through literature and survey data reviews as well as nine country case studies, the working group identified pharmacists as having expertise that is critical to supply chain integrity. The report gives a global overview of the role of pharmacists in different supply chains in low-, middle- and high-income countries, and describes the evolution of supply chains. “The report recognises different levels of maturity of supply systems that could be used as a basis for discussion, particularly in developing countries. It doesn’t aim to describe a single gold standard system, but, rather, it seeks to highlight that all systems should ensure efficient supply of quality medicines. It also draws attention to the effect of globalisation on the supply chain.
Importantly, the report points out that investment in training and education are needed to strengthen pharmacists’ roles in supply chains.